drug · small molecule
PROGESTERONE
Marketedupdated 5mo agoby IBSA Institut Biochimique SA🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval77 co-mentions · 22 sources
- tagSmall Molecule36 co-mentions · 19 sources
- drugESTRING4 co-mentions · 2 sources
- companyEugia US LLC2 co-mentions · 1 sources
- tagRecall2 co-mentions · 2 sources
- companyAll India Institute of Medical Sciences1 co-mentions · 1 sources
- companyUniversity of Utah1 co-mentions · 1 sources
- tagWomen's Health1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 35 investigational indications.
targets
Progesterone receptor
all catalysts(3)
Trials studying PROGESTERONE
- phase1First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency
- phase3A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
- phase3Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
- phase3Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
- phase4Exogenous Progesterone as Ovulation Trigger
- phase3Individualized Prolonged Luteal Support After Fresh Embryo Transfer in Women With Low Progesterone
- phase2A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- phase4Menopausal HT for Women Living With HIV (HoT)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 3, 2029
~2.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Jan 21, 2030method-of-use (U-2810)US 85802933.3y
- Feb 3, 2029formulationUS 105375842.3y
- Feb 3, 2029method-of-use (U-2810)US 105489042.3y
FDA exclusivities (1)
- Mar 22, 2026CGTCGT
News(2)
- Opinion: Telehealth abortion with mifepristone continues, with backup plans still in placeRestricting telehealth prescribing of mifepristone wouldn't spell the end of telehealth medication abortion, writes OB-GYN Christine Henneberg.stat · 4mo ago
- Opinion: STAT readers on MAHA activists, perimenopause, and diversity in medical school“Unfortunately, the resources don't exist to take every flat-earther to the International Space Station to change their mind,” a STAT reader writes.stat · 5mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that